Clinical research program manager
Emily Misnick is a dedicated researcher with experience managing clinical trial sites investigating psychedelic-assisted therapy. She is passionate about investigating the transformative effects of psychedelics on mental health and wellbeing.
Emily received her master’s degree in biomedical engineering from the University of California, Davis, and her bachelor’s in biomedical engineering from Boston University. With an interest in exploring the intersection of science and medicine, she delved into research in tissue engineering, pharmacology, and then clinical research. With her multidisciplinary expertise, Emily is dedicated to the integration of cutting-edge research and clinical practices to advance accessible mental health treatments.
Emily served as Clinical Research Coordinator for the Multidisciplinary Association for Psychedelic Studies (MAPS) Phase 3 trials of MDMA-Assisted Therapy for Post Traumatic Stress Disorder. In addition to Clinical Research Program Manager at OMC, she is currently Clinical Research Coordinator for a Beckley Psytech–sponsored trial of 5-MeO-DMT for Treatment-Resistant Depression.